Department of Medicine

November 6, 2014

Autonomic diseases consortium lands renewed federal funding

A nationwide research group headed by Vanderbilt University’s David Robertson, M.D., has received another round of funding from the federal government to continue studies of rare neurodegenerative diseases and disorders affecting blood pressure.

By Bill Snyder
November 6, 2014

Diabetes effort aims to boost function of insulin-producing cells

Vanderbilt University is part of a national effort to improve diabetes treatment by developing strategies for proliferating, regenerating and improving the function of insulin-producing beta cells in the pancreatic islets.

By Bill Snyder
kidney x-ray
October 30, 2014

NIH grant spurs diabetic nephropathy research

Diabetic nephropathy, or kidney disease caused by diabetes, is a major source of morbidity and mortality. In the United States, more than 30 percent of patients receiving either dialytic therapy or renal transplantation have end stage renal disease as a result of diabetic nephropathy.

By Kathy Whitney
October 24, 2014

Immune cells’ role in hypertension

Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease.

By Leigh MacMillan
October 23, 2014

VICC investigators earn breast cancer grants

The grants, which total $830,000, are part of the non-profit organization’s commitment to young scientists, as well as established investigators who are searching for more effective breast cancer therapies.

By VUMC News and Communications
Laura Dugan, Abram C. Shmerling, M.D. Professor of Alzheimer’s and Geriatric Medicine
October 20, 2014

New faculty: Dugan explores complexities of Alzheimer’s

Laura Dugan strives to bring breakthroughs in neuroscience research and the aging brain together.

By Nancy Humphrey
October 10, 2014

Aspirin and allergies

Drugs such as aspirin and indomethacin may increase sensitivity to airborne allergens by suppressing production of the signaling molecule PGI2, which in turn may offer a new treatment for allergies.
By VUMC News and Communications
October 2, 2014

Team spots key regulator for cholesterol production

A Vanderbilt University-led research team has discovered a “master regulator” for cholesterol production and transport in the liver — a tiny piece of RNA called microRNA-223.
By Bill Snyder
September 25, 2014

A path to sarcoidosis treatment

Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.
By VUMC News and Communications
September 18, 2014

Prevention key to fight familial hypercholesterolemia

Imagine an inherited cause of early heart attacks that is more common than type-1 diabetes, multiple sclerosis or cystic fibrosis, but goes largely unrecognized.
By Matt Batcheldor
September 18, 2014

State public health award named for Schaffner

The Tennessee Public Health Association and the Tennessee Medical Association are collaborating to establish the “William Schaffner, M.D., Public Health Hero Award,” to be presented annually to an individual who has demonstrated extraordinary efforts in the advancement of public health in Tennessee.
By Craig Boerner
September 4, 2014

Lung cancer study reveals new drug combination targets

A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways.
By VUMC News and Communications
August 21, 2014

Major grant spurs deeper look into ‘good cholesterol’

In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis.
By Bill Snyder
1 … 101 102 103 104 105 … 123